Netflix should see accelerated subscriber growth and slower subscriber churn with the launch of its lower-priced ad tier, analysts at Oppenheimer believe.
“Despite increased competition, Netflix remains the dominant streaming platform maintaining the largest market share of US TV viewership,” Oppenheimer analysts wrote following the streaming giant’s 1Q results.
IBM’s first-quarter results were “better than feared” after higher margins counteracted the computing firm’s revenue miss, said Wedbush.
Analysts were buoyed by IBM’s quarterly results, which came in ahead of first-quarter 2023 adjusted earnings of $1.36 per share, surpassing the consensus estimate of $1.26 per share.
Drill results from Talon Metals Corp’s newly-discovered Raptor Zone at its Tamarack nickel-copper-cobalt project located in Minnesota have highlighted the district scale and high-grade resource growth potential of the project, according to analysts at Stifel GMP.
In a note to clients, analysts wrote that the results showcased high-grade albeit narrow intercepts reaffirming the strong regional potential and room for resource growth within the complex.
United Airlines is in a “very good position” to meet its flat cost per available seat mile (CASM) expenses goal for the year after reporting strong 1Q earnings, according to analysts at Deutsche Bank.
The investment house analysts said that a better March quarter, strong international demand, and improving unit costs its supportive of “substantial” EPS growth following the release of United’s results.
Teck Resources has turned down yet another takeover offer from Glencore and urged shareholders to vote for its separation plan in a letter to investors on Wednesday.
Teck wrote in the letter that Glencore’s latest presentation and open letter included no changes from its previous offer, which the company has reviewed and rejected.
Curaleaf’s recreational license renewal in New Jersey, a reversal of the state’s Cannabis Regulatory Commission’s (CRC's) earlier decision, is a positive development for the company according to Stifel GMP analysts.
“As a result, we no longer intend to revise our forecasts based on this past week’s events and will wait for 4Q FY22 results to update our outlook, with a focus on gaining greater clarity on management's industry-high guidance of greater than $125 million 2023 free cash flow,” the analysts wrote in a note to clients.
MustGrow Biologics Corp has earned a repeat ‘Market Perform’ rating from Noble analysts after the company announced it is pursuing sustainable agriculture opportunities in the soil amendment and biofertility markets.
The new programs will focus on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields, the company said on Tuesday.
Haleon PLC (LSE:HLN, NYSE:HLN) has "achievable" sales targets but it may struggle to meet the market's expected level of profit margins, according to Barclays.
Analysts at the bank reiterated their "overweight" rating and 383p share price target.
Investors holding Netflix Inc (NASDAQ:NFLX) shares will benefit from a “reacceleration” of revenue growth through the next twelve months, that’s according to analysts at Deutsche Bank.
The team at Deutsche, which rates Netflix as a ‘buy’, reacted to last night’s results statement by nudging higher their price target to US$410 per share, from US$400, suggesting some 22% upside to Tuesday’s close.
AFC Energy’s first hydrogen-generator order from contractor Acciona reflects feedback from the Spanish group after a trial of a smaller version, notes broker Peel Hunt.
Acciona’s engineers gave a detailed definition of shape, size and power output that an emission-free generator should have to hit the construction industry's mass adoption “sweet spot”, notes the house broker.
Reunion Gold Corporation (TSX-V:RGD, OTCQB:RGDFF) has retained a ‘Buy’ rating and C$0.60 price target from analysts at Stifel GMP after the company announced additional drill results from its Oko West project in Guyana that expanded the high-grade mineralization at depth in Block 4.
Analysts at the US brokerage noted that assay highlights include 5.6 grams per tonne (g/t) gold over 109.7 metres (m), 4.13 g/t over 65.4m, and 5.16 g/t over 18.5m.
Introduction: We asked Proactive's mining analyst, Ryan Long, to take a look at Mink Ventures Corporation (TSX-V:MINK), which is exploring the potential of its strategic landholding in the Abitibi Belt of Ontario, Canada. The company's primary asset, the Montcalm Nickel Project (map below), offers several promising aspects for investors. Here's what Ryan had to say:
Strategic location: Mink's Montcalm Nickel Project covers around 33% of the Montcalm Gabbro Complex. The area is strategically located next door to Glencore's Montcalm Mine, which produced 3.93mlb tonnes of ore containing 1.25 % nickel and additional copper and cobalt between 2005 and 2009. The mine’s infrastructure including a plant that is on care and maintenance provides significant advantages for the development of Mink's exploration project.
The Coppock Curve, a little-known stock market indicator, has just called the start of a new bull market.
While the name may not be familiar to most retail investors the Coppock Curve has, since being invented in the 1960s by a churchgoing economist, consistently signalled the start of a new bull market (apart from in 2001).
Thor Explorations remains Canaccord Genuity (TSX:CF, LSE:CF)’s top London gold producer pick after posting its first quarter 2023 operational update, with the miner reporting the production of 20,629 ounces of gold at its Segilola mine in Nigeria.
In a note to clients, Canaccord analysts reiterated their ‘Buy’ rating for the stock and price target of 35p. Thor’s London-listed shares are currently trading at 19p.
Analysts at Canaccord Genuity (TSX:CF, LSE:CF) are not yet updating their estimates for Curaleaf as the cannabis producer appeals the New Jersey Cannabis Regulatory Commission’s (CRC’s) vote against renewing its adult-use retail and cultivation licenses in the state as of April 21, 2023.
Curaleaf said in a statement on April 14 that it has fulfilled the requirements necessary for the renewal of its licenses, it has never received any violation notices from the CRC to allow it to remedy the concern, and it will work with the CRC to ensure the renewal of its licenses.
Peel Hunt reiterated its 'buy' recommendation and a 524p per share price target for Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) following the latest update from its phase I/II trial of the lead asset, a cancer drug called bexmarilimab.
The broker noted that one of the highlights of Monday's announcement was the drug's apparent ability to ignite an immune response in a patient who wasn't previously responding to the standard of care treatment, azacytidine.
Universal Music, is at heart, a store of millions of contracts and rights that generate royalties representing a store of value with fast-growing annuity streams says the US broker.
That store of value is unlikely to diminish, adds the US bank, noting that catalogues or old music now account for 75% of the market, up from 56% in 2016 despite all the new music since then (source: BRI).